Rodman & Renshaw Capital Group, Inc. operates as a full-service investment bank, providing investment banking services to companies that have recurring capital needs. The company, through its life science investment banking unit, provides corporate finance and strategic advisory services to biotechnology, specialty pharmaceutical, medical device, and other companies operating in the life science space. Its corporate finance activities are principally focused on public and private equity products, including private investment in public equity (PIPEs), where a public reporting company sells unregistered securities of a class and/or convertible or exchangeable for a class that is already publicly traded; registered direct offerings (RDs), which are direct placements of securities that have been registered under a shelf registration statement; private placements; and public offerings. Rodman & Renshaw Capital Group also provides strategic advisory services in connection with mergers, acquisitions, dispositions, and similar transactions. Its other services include research, sales and trading, and merchant banking. The company is based in New York, New York.